Matt Lasmanis
Chief Digital Officer, Jazz Pharmaceuticals
In this DHCG Disruptive Dose, Mark Bard speaks with Matt Lasmanis, Chief Digital Officer at Jazz Pharmaceuticals, about leading digital transformation within a mid-size specialty pharma organization. Lasmanis emphasizes focusing digital innovation where technology creates genuine clinical and commercial value rather than pursuing transformation for its own sake. He discusses building organizational digital fluency alongside technical capabilities, navigating AI implementation with appropriate governance, and balancing innovation speed with regulatory compliance. Lasmanis offers practical perspective on prioritizing digital investments and building internal credibility by connecting technology decisions directly to patient and business outcomes.